Chimeric Therapeutics Limited (ASX:CHM)

Chimeric Therapeutics Statistics

Total Valuation

ASX:CHM has a market cap or net worth of AUD 8.84 million. The enterprise value is 6.33 million.

Market Cap	8.84M
Enterprise Value	6.33M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:CHM has 4.42 billion shares outstanding. The number of shares has increased by 168.67% in one year.

Current Share Class	4.42B
Shares Outstanding	4.42B
Shares Change (YoY)	+168.67%
Shares Change (QoQ)	+69.04%
Owned by Insiders (%)	18.74%
Owned by Institutions (%)	5.51%
Float	3.50B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.91
PB Ratio	-2.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.34
EV / Sales	0.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.69

Current Ratio	0.69
Quick Ratio	0.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.81

Financial Efficiency

Return on equity (ROE) is -1,290.99% and return on invested capital (ROIC) is -218.87%.

Return on Equity (ROE)	-1,290.99%
Return on Assets (ROA)	-25.89%
Return on Invested Capital (ROIC)	-218.87%
Return on Capital Employed (ROCE)	350.62%
Weighted Average Cost of Capital (WACC)	12.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.79
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:CHM has paid 16,158 in taxes.

Income Tax	16,158
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.23% in the last 52 weeks. The beta is 1.49, so ASX:CHM's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-69.23%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.74
Average Volume (20 Days)	7,506,784

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CHM had revenue of AUD 9.75 million and -18.79 million in losses. Loss per share was -0.01.

Revenue	9.75M
Gross Profit	8.90M
Operating Income	-5.10M
Pretax Income	-18.77M
Net Income	-18.79M
EBITDA	-4.04M
EBIT	-5.10M
Loss Per Share	-0.01

Balance Sheet

The company has 2.50 million in cash and n/a in debt, with a net cash position of 2.50 million or 0.00 per share.

Cash & Cash Equivalents	2.50M
Total Debt	n/a
Net Cash	2.50M
Net Cash Per Share	0.00
Equity (Book Value)	-3.03M
Book Value Per Share	-0.00
Working Capital	-2.26M

Cash Flow

Operating Cash Flow	-8.49M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 91.32%, with operating and profit margins of -52.27% and -192.71%.

Gross Margin	91.32%
Operating Margin	-52.27%
Pretax Margin	-192.54%
Profit Margin	-192.71%
EBITDA Margin	-41.39%
EBIT Margin	-52.27%
FCF Margin	n/a

Dividends & Yields

ASX:CHM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-168.67%
Shareholder Yield	-168.67%
Earnings Yield	-212.60%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2